What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Molecular biology, Estrogen receptor beta, Cancer research, Estrogen receptor alpha and Regulation of gene expression.
Estrogen receptor beta is a subfield of Estrogen receptor that Alessandro Weisz studies.
In his study, RNA is strongly linked to Cell biology, which falls under the umbrella field of Estrogen receptor.
His research in Cancer research tackles topics such as Cyclin A2 which are related to areas like Cyclin D.
His study in Estrogen receptor alpha is interdisciplinary in nature, drawing from both Transcription factor and Sp1 transcription factor.
His Regulation of gene expression study integrates concerns from other disciplines, such as Enhancer, Gene expression and Transcriptional regulation.
His most cited work include:
- Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. (525 citations)
- Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide (395 citations)
- 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. (317 citations)
What are the main themes of his work throughout his whole career to date?
Alessandro Weisz mainly focuses on Cancer research, Cell biology, Estrogen receptor, Molecular biology and Internal medicine.
His work deals with themes such as Breast cancer, Hormone Responsive, Bioinformatics, microRNA and Regulation of gene expression, which intersect with Cancer research.
Alessandro Weisz works mostly in the field of Cell biology, limiting it down to concerns involving Interactome and, occasionally, Proteomics.
His biological study focuses on Estrogen receptor beta.
His Estrogen receptor beta study frequently links to related topics such as Estrogen receptor alpha.
In his study, Cell growth is inextricably linked to Cell cycle, which falls within the broad field of Molecular biology.
He most often published in these fields:
- Cancer research (39.90%)
- Cell biology (28.08%)
- Estrogen receptor (27.59%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (39.90%)
- microRNA (15.27%)
- Cell biology (28.08%)
In recent papers he was focusing on the following fields of study:
Alessandro Weisz focuses on Cancer research, microRNA, Cell biology, Regulation of gene expression and Estrogen receptor.
His research in Cancer research intersects with topics in Cell growth, Estrogen receptor alpha, Chromatin, Targeted therapy and Epigenetics.
His microRNA research incorporates themes from Phenotype and Bioinformatics.
The various areas that Alessandro Weisz examines in his Cell biology study include RNA, Non-coding RNA, RNA splicing, Proteomics and Piwi-interacting RNA.
The study incorporates disciplines such as Transcriptional regulation, Molecular biology, Estrogen receptor beta, Triple-negative breast cancer and Chromatin remodeling in addition to Regulation of gene expression.
His study in the field of Antiestrogen also crosses realms of Adiponectin.
Between 2016 and 2021, his most popular works were:
- DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. (44 citations)
- TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness. (28 citations)
- The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading (28 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cancer research, microRNA, Cell biology, Regulation of gene expression and Molecular biology.
His Cancer research research includes themes of Cell metabolism, Artery, Epigenetics and Estrogen receptor.
His work deals with themes such as Myocyte, Phenotype, Downregulation and upregulation and Experimental pathology, which intersect with microRNA.
His Cell biology study integrates concerns from other disciplines, such as Genome editing, CRISPR, Annexin A1, RNA splicing and Cytoskeleton.
His studies in Regulation of gene expression integrate themes in fields like RNA-induced silencing complex, Transcriptional regulation, Argonaute, Cell cycle and Kinase.
His studies deal with areas such as Methylation, Lung cancer, Pathology, Mir 196a and Pi3k akt signaling as well as Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
